RecruitingPhase 3NCT04743141

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age

Sponsor

Pfizer

Enrollment

600 participants

Start Date

Apr 28, 2021

Study Type

INTERVENTIONAL

Conditions

Acute Treatment of Migraine

Summary

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of age).

Eligibility

Min Age: 6 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Rimegepant (PF-07899801) for people with acute treatment of migraine. The study is currently recruiting participants at 125 locations. People eligible for this study include aged 6 Years to 17 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRimegepant (PF-07899801)

Rimegepant 75 mg, 50 mg or 35 mg ODT

Locations(124)

Perseverance Research Center, LLC

Scottsdale, Arizona, United States

Physicians Research Group

Tempe, Arizona, United States

Advanced Research Center, Inc.

Anaheim, California, United States

ProScience Research Group

Culver City, California, United States

Neuro-Pain Research Center

Fresno, California, United States

Altman Clinical and Translational Research Institute, University of California San Diego

La Jolla, California, United States

Adult & Child Neurology Medical Associates

Long Beach, California, United States

Memorialcare Miller Children's & Women's Hospital Long Beach

Long Beach, California, United States

Velocity Clinical Research - North Hollywood

North Hollywood, California, United States

The Neurology Group

Pomona, California, United States

UC Davis Medical Center, Investigational Drug Service (IDS) Pharmacy

Sacramento, California, United States

University of California, Davis Clinical and Translational Science Center Clinical Research Center

Sacramento, California, United States

University of California, Davis Midtown Clinic

Sacramento, California, United States

Velocity Clinical Research- Banning

San Bernardino, California, United States

Pacific Clinical Research Management Group LLC

Upland, California, United States

Sunwise Clinical Research

Walnut Creek, California, United States

Children's Hospital Colorado- Investigational Drug Services

Aurora, Colorado, United States

Children's Hospital Colorado

Aurora, Colorado, United States

Colorado Springs Neurological Associates, PC

Colorado Springs, Colorado, United States

Colorado Springs Neurological Associates, PC

Colorado Springs, Colorado, United States

Boeson Research GJT

Grand Junction, Colorado, United States

Dinosaur Pediatrics

Grand Junction, Colorado, United States

Boeson Research GJT

Grand Junction, Colorado, United States

CT Clinical Research

Cromwell, Connecticut, United States

Ki Health Partners, LLc, dba New England Institute for Clinical Research

Stamford, Connecticut, United States

Children's National Medical Center

Washington D.C., District of Columbia, United States

AppleMed Research Group, LLC

Miami, Florida, United States

Medical Research Center of Miami II, Inc

Miami, Florida, United States

South Florida Research Phase I-IV, Inc

Miami, Florida, United States

Physicians Group Services, PA d/b/a Coastal Health Research

Orange Park, Florida, United States

Clinical Associates of Orlando, LLC

Orlando, Florida, United States

ForCare Clinical Research

Tampa, Florida, United States

Premiere Research Institute at Palm Beach Neurology

West Palm Beach, Florida, United States

Rare Disease Research LLC

Atlanta, Georgia, United States

Pivotal Clinical Research & Associates, LLC

Brunswick, Georgia, United States

CenExel iResearch, LLC

Decatur, Georgia, United States

Chicago Headache Center & Research Institute

Chicago, Illinois, United States

AMR-Baber Research Inc

Naperville, Illinois, United States

Options Research Group, LLC

Westfield, Indiana, United States

Integrated Clinical Trial Services, Inc.

West Des Moines, Iowa, United States

Clinical Associates Midwest, LLC

Kansas City, Kansas, United States

University of Kentucky Hospital

Lexington, Kentucky, United States

Ochsner Clinic Foundation

New Orleans, Louisiana, United States

MedVadis Research Corporation

Waltham, Massachusetts, United States

Michigan Head Pain and Neurological Institute

Ann Arbor, Michigan, United States

Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group

Grand Rapids, Michigan, United States

Corewell Health, Helen DeVos Children's Hospital

Grand Rapids, Michigan, United States

Wellnow Urgent Care and Research

Kalamazoo, Michigan, United States

Beaumont Hospital, Royal Oak Campus

Royal Oak, Michigan, United States

Sharlin Health Neuroscience Research Center

Ozark, Missouri, United States

Clinvest Research, LLC

Springfield, Missouri, United States

Boeson Research

Great Falls, Montana, United States

Heart & Hands Midwifery

Kalispell, Montana, United States

Blue Moose Pediatrics

Missoula, Montana, United States

Boeson Research Laboratory

Missoula, Montana, United States

Boeson Research

Missoula, Montana, United States

Alivation Research, LLC

Lincoln, Nebraska, United States

Children's Hospital & Medical Center

Omaha, Nebraska, United States

HMH Jersey Shore University Medical Center

Neptune City, New Jersey, United States

Hope Tower

Neptune City, New Jersey, United States

Dent Neurosciences Research Center

Amherst, New York, United States

True North Neurology

Commack, New York, United States

New York Neurology Associates